ELIZABETH ANN WALLACE FNP-BC NPI 1982159356

NPI Details

Elizabeth Ann Wallace, FNP-BC is a family nurse practitioner in Knoxville, TN with 9 years of experience. Elizabeth Ann Wallace, FNP-BC NPI is 1982159356. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

2001 LAUREL AVE STE 105
KNOXVILLE, TN
ZIP 37916-867
Phone: (865) 577-9247
Fax: (833) 908-2095

The NPI 1982159356 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Hemoglobin a1c level (HCPCS:83036)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Automated urinalysis test (HCPCS:81003)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Lipase (fat enzyme) level (HCPCS:83690)
• Test to assess middle ear function (HCPCS:92567)
• Placement of ear probe for computerized measurement of repeated sounds with interpretation and report (HCPCS:92588)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)

The enumeration date for this NPI number is 8/16/2016 and was last updated on 9/6/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: